# Cagrilintide pediatric study record updated

> ClinicalTrials.gov lists a recruiting Cagrilintide study sponsored by Novo Nordisk A/S.

- Evidence object: `story:cagrilintide-pediatric-study-updated:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-17
- Source checked: 2026-07-22
- Published by PeptideScanner: 2026-07-22
- Story landing page: https://peptidescanner.com/stories/cagrilintide-pediatric-study-updated/
- JSON record: https://peptidescanner.com/evidence/v1/objects/cagrilintide-pediatric-study-updated-v1.json
- Content SHA-256: `4d1e2d9e1b80ca7780f28f1befb13fcc502c1f8e12c92899a9939b513037cecc`

## Claims and source pins

### Headline

Cagrilintide pediatric study record updated ([`ctg-nct07253285-v5`](#source-ctg-nct07253285-v5))

### Summary

ClinicalTrials.gov lists a recruiting Cagrilintide study sponsored by Novo Nordisk A/S. ([`ctg-nct07253285-v5`](#source-ctg-nct07253285-v5))

### Paragraph 1

ClinicalTrials.gov lists the NCT07253285 record under Novo Nordisk A/S. Its overall recruitment status was shown as recruiting when PeptideScanner reviewed the record. ([`ctg-nct07253285-v5`](#source-ctg-nct07253285-v5))

### Paragraph 2

The registry shows 2026-07-17 as its latest posted update date. This update reports the registry record and does not establish safety, effectiveness, or a trial outcome. ([`ctg-nct07253285-v5`](#source-ctg-nct07253285-v5))

## Sources

<a id="source-ctg-nct07253285-v5"></a>
- **Cagrilintide and CagriSema in Children and Adolescents With Excess Body Weight · record history version 5 · last update posted 2026-07-17** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07253285?a=5&tab=history) (`ctg-nct07253285-v5`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Cagrilintide pediatric study record updated." Version 1, published 2026-07-22. https://peptidescanner.com/evidence/v1/objects/cagrilintide-pediatric-study-updated-v1.json SHA-256: 4d1e2d9e1b80ca7780f28f1befb13fcc502c1f8e12c92899a9939b513037cecc.